[HTML] sciencedirect.com

[HTML][HTML] Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - Annals of …, 2019 - Elsevier
ABSTRACT Background The National Lung Screening Trial showed that lung cancer (LC)
screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC …
被引用次数：534 相关文章

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia… - Annals of …, 2019 - annalsofoncology.org
ABSTRACT Background The National Lung Screening Trial showed that lung cancer (LC)
screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC …
[HTML] nih.gov

[HTML][HTML] Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - Annals of …, 2019 - ncbi.nlm.nih.gov
Background The National Lung Screening Trial showed that lung cancer (LC) screening by
three annual rounds of low-dose computed tomography (LDCT) reduces LC mortality. We …

Erratum: ERRATUM: Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: New confirmation of lung cancer screening efficacy (Ann Oncol …

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - 2019 - boa.unimib.it
Erratum: ERRATUM: Prolonged lung cancer screening reduced 10-year mortality in the MILD
trial: New confirmation of lung cancer screening efficacy (Ann Oncol (2019) DOI:10.1093/annonc/mdz117) …

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - 2019 - cabidigitallibrary.org
Abstract Background: The National Lung Screening Trial showed that lung cancer (LC)
screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC …

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.

U Pastorino, M Silva, S Sestini, F Sabia… - Annals of Oncology …, 2019 - europepmc.org
Background The National Lung Screening Trial showed that lung cancer (LC) screening by
three annual rounds of low-dose computed tomography (LDCT) reduces LC mortality. We …

[引用][C] Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - Annals of …, 2019 - cir.nii.ac.jp
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new
confirmation of lung cancer screening efficacy | CiNii Research CiNii 国立情報学研究所 学術 …
[PDF] semanticscholar.org

[PDF][PDF] Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia… - Annals of …, 2019 - pdfs.semanticscholar.org
Background: The National Lung Screening Trial showed that lung cancer (LC) screening by
three annual rounds of low-dose computed tomography (LDCT) reduces LC mortality. We …

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - ANNALS OF …, 2019 - air.unipr.it
Background The National Lung Screening Trial showed that lung cancer (LC) screening by
three annual rounds of low-dose computed tomography (LDCT) reduces LC mortality. We …

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - Annals of …, 2019 - academia.edu
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new
confirmation of lung cancer screening efficacy Page 1 ERRATUM Prolonged lung cancer …